glp-1 regulatory news Science's 2023 Breakthrough: GLP-1R Agonists September 15, 2025: Telehealth company

This approach may require closer cooperation between endocrinologists, neurologists, and geriatricians to leverage semaglutides potential in cognitive health fully

Both administration types have shown meaningful weight loss in clinical trials

Early intervention can prevent complications

doi:10.1001/jamanetworkopen.2024.57349 NICE (2025) Quality statement 7: Advice and support after stopping medicines for weight management or completing behavioural interventions (Accessed: 10 August 2025)

16 Based on these data, it is reasonable to decrease background prandial insulin doses by 50%, or even hold the prandial insulin altogether in patients with good glucose control or a history of hypoglycemia when starting a GLP-1 RA